CONSENSUS BY THE COLLECTIVE OF PSYCHIATRISTS FOR THE CLOZAPINE UPDATE.

"CONFLICTS OF INTEREST MB has been a consultant, has received grants/research support and/or honoraria from, and/or has been a speaker/ advisor for ABBiotics, Adamed, Angelini, Casen Recordati, Janssen-Cilag, Menarini, Rovi, and Takeda. EFE has received consultancy honoraria from Boehringer-Ingelheim (2022), Atheneum (2018-2022), received training and research material from Merz (2020) and is director of a private practice company (cambridgepsychiatry.co.uk). EFE has received research funding from MRC/NIHR (2021 Clinician Academic Research Partnership), Cambridge BRC and NIHR-HTA. EFE has received consultancy honoraria from Boehringer- Ingelheim (2022), Atheneum (2022) and Rovi (2022), speaker fees by Adamed (2022) and Otsuka (2023) and training and research material from Merz (2020)."